CircETV6 acts as an oncogenic driver in hepatocellular carcinoma progression
Journal of Biochemical and Molecular Toxicology · 2024
DOI: 10.1002/jbt.23766 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2024. Verfasst von Xiaoqin Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Laboratory, Urumqi Maternal and Child Health Care Hospital, Urumqi, Xinjiang, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, RNA, Circular, Proto-Oncogene Proteins c-ets. Die Arbeit nennt 37 Literaturangaben.
Abstract (Originalsprache)
Circular RNA (circRNA) plays important role in hepatocellular carcinoma (HCC) progression. However, the role and mechanism of circETV6 in HCC progression remain unclear. The levels of circETV6, ETV6, miR‐383‐5p, and PTPRE were tested by quantitative reverse‐transcription polymerase chain reaction. Cell functions were assessed using the 3‐(4,5‐dimethyl‐2‐thiazolyl)‐2,5‐diphenyl‐2H‐tetrazolium bromide assay, 5‐ethynyl‐2′‐deoxyuridine assay, colony formation assay, wound healing assay, transwell assay, and flow cytometry. The protein levels of poptosis‐related markers and PTPRE were determined by western blot analysis. RNA interaction was analyzed by dual‐luciferase reporter assay and RNA pull‐down assay. A xenograft model was established to assess circETV6 roles in vivo. CircETV6 was highly expressed in HCC tissues and cells. CircETV6 knockdown repressed HCC cell proliferation, migration, invasion, and cell cycle, while accelerated apoptosis. CircETV6 targeted miR‐383‐5p, and miR‐383‐5p inhibition reversed the regulation of circETV6 knockdown on HCC cell progression. CircETV6 promoted PTPRE level via targeting miR‐383‐5p. Overexpressed PTPRE abolished the inhibition effect of miR‐383‐5p on HCC cell progression. In addition, circETV6 knockdown slowed HCC tumor growth in vivo. CircETV6 might facilitate HCC progression via the miR‐383‐5p/PTPRE axis, providing a novel target for HCC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Laboratory, Urumqi Maternal and Child Health Care Hospital, Urumqi, Xinjiang, China.
- Department of Gynecology, Urumqi Maternal and Child Health Care Hospital, Urumqi, Xinjiang, China.
- Clinical Laboratory Center, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China.
Zitieren
APA
Li, X., Jiang, X., Lu, J., Jiang, L., Li, Y., Lin, Y., Wan, F., & Wang, C. (2024). CircETV6 acts as an oncogenic driver in hepatocellular carcinoma progression. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.23766
Vancouver
Li X, Jiang X, Lu J, Jiang L, Li Y, Lin Y, et al. CircETV6 acts as an oncogenic driver in hepatocellular carcinoma progression. Journal of Biochemical and Molecular Toxicology. 2024. doi:10.1002/jbt.23766
BibTeX
@article{Li2024,
author = {Li, Xiaoqin and Jiang, Xuemei and Lu, Jing and Jiang, Lan and Li, Yan and Lin, Yuting and Wan, Feng and Wang, Changmin},
title = {CircETV6 acts as an oncogenic driver in hepatocellular carcinoma progression},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2024},
doi = {10.1002/jbt.23766}
}
EUVIMED